Skip to main content

Advertisement

Log in

Risk factors for urinary tract infection following incontinence surgery

  • Original Article
  • Published:
International Urogynecology Journal Aims and scope Submit manuscript

Abstract

Introduction and hypothesis

The purpose of this study is to describe risk factors for post-operative urinary tract infection (UTI) the first year after stress urinary incontinence surgery.

Methods

Multivariable logistic regression analyses were performed on data from 1,252 women randomized in two surgical trials, Stress Incontinence Surgical Treatment Efficacy trial (SISTEr) and Trial Of Mid-Urethral Slings (TOMUS).

Results

Baseline recurrent UTI (rUTI; ≥3 in 12 months) increased the risk of UTI in the first 6 weeks in both study populations, as did sling procedure and self-catheterization in SISTEr, and bladder perforation in TOMUS. Baseline rUTI, UTI in the first 6 weeks, and PVR > 100 cc at 12 months were independent risk factors for UTI between 6 weeks and 12 months in the SISTEr population. Few (2.3–2.4%) had post-operative rUTI, precluding multivariable analysis. In women with pre-operative rUTI, successful surgery (negative cough stress test) at 1 year did not appear to decrease the risk of persistent rUTI.

Conclusions

Pre-operative rUTI is the strongest risk factor for post-operative UTI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Foxman B (2002) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 113(Suppl 1A):5S–13S

    Article  PubMed  Google Scholar 

  2. Albo ME, Richter HE, Brubaker L, Norton P, Kraus S, Zimmern PE et al (2007) Burch coloposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med 356:2143–2155

    Article  PubMed  CAS  Google Scholar 

  3. Anger JT, Litwin MS, Wang Q, Pashos CL, Rodriquez LV (2007) Complication of sling surgery among female Medicare beneficiaries. Obstet Gynecol 109:707–714

    Article  PubMed  Google Scholar 

  4. Kunin CM (1994) Urinary tract infections in females. Clin Infect Dis 18:1–10

    Article  PubMed  CAS  Google Scholar 

  5. Melville JL, Katon W, Delaney K, Newton K (2005) Urinary incontinence in US women: a population-based study. Arch Intern Med 165:537–542

    Article  PubMed  Google Scholar 

  6. Hooton TM, Scholes D, Hughes JP, Winter C, Roberts PL, Stapleton AE, Stergachis A, Stamm WE (1996) A prospective study of risk factors for symptomatic urinary tract infection in young women. NEJM 335:468–474

    Article  PubMed  CAS  Google Scholar 

  7. Brown JS, Grady D, Ouslander JG, Herzog AR, Varner RE, Posner SF (1999) Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen/Progestin Replacement Study (HERS) Research Group. Obstet Gynecol 94:66–70

    Article  PubMed  CAS  Google Scholar 

  8. Brown JS, Vittinghoff E, Kanaya AM, Agarwal SK, Hulley S, Foxman B et al (2001) Urinary tract infections in postmenopausal women: effect of hormone therapy and risk factors. Obstet Gynecol 98:1045–1052

    Article  PubMed  CAS  Google Scholar 

  9. Foxman B, Somsel P, Tallman P, Gillespie B, Raz R, Colodner R et al (2001) Urinary tract infection among women aged 40 to 65: behavioral and sexual risk factors. J Clin Epidemiol 54:710–718

    Article  PubMed  CAS  Google Scholar 

  10. Hu KK, Boyko EJ, Scholes D, Normand E, Chen CL, Grafton J et al (2004) Risk factors for urinary tract infections in postmenopausal women. Arch Intern Med 164:989–993

    Article  PubMed  Google Scholar 

  11. Raz R, Gennesin Y, Wasser J, Stoler Z, Rosenfeld S, Rottensterich E, Stamm WE (2000 Jan) Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis 30(1):152–156

    Article  PubMed  CAS  Google Scholar 

  12. Moore EE, Jackson SL, Boyko EJ, Scholes D, Fihn SD (2008 Feb) Urinary incontinence and urinary tract infection: temporal relationships in postmenopausal women. Obstet Gynecol 111(2 Pt 1):317–323

    Article  PubMed  Google Scholar 

  13. Richter HE, Albo ME, Zyczynski HM et al (2010 Jun 3) Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med 362(22):2066–2076

    Article  PubMed  CAS  Google Scholar 

  14. FitzGerald MP, Richter HE, Bradley CS, Ye W, Visco AC, Cundiff GW, Zyczynski HM, Fine P, Weber AM (2008) Pelvic support, pelvic symptoms, and patient satisfaction after colpocleisis. Int Urogynecol J 19:1603–1609

    Article  CAS  Google Scholar 

  15. Sutkin G, Lowder JL, Smith KJ (2009) Prophylactic antibiotics to prevent urinary tract infection during clean intermittent self-catheterization (CISC) for management of voiding dysfunction after prolapse and incontinence surgery: a decision analysis. Int Urogynecol J 20:933–938

    Article  Google Scholar 

  16. Stern JA, Hsieh Y, Schaeffer AJ (2004) Residual urine in an elderly female population: novel implications for oral estrogen replacement and impact on recurrent urinary tract infection. J Urol 171:768–770

    Article  PubMed  CAS  Google Scholar 

  17. Hampson SJ, Noble JG, Rickards D, Milroy EJ (1992) Does residual urine predispose to urinary tract infection? Br J Urol 70:506

    PubMed  CAS  Google Scholar 

  18. Phipps S, Lim YN, McClinton S, Barry C, Rane A, N'Dow J (2006) Short term urinary catheter policies following urogenital surgery in adults. Cochrane Database Syst Rev 19(2):CD004374

    Google Scholar 

  19. Hammar N, Farahmand B, Gran M, Joelson S, Andersson SW (2010) Incidence of urinary tract infection in patients with type 2 diabetes. Experience from adverse event reporting in clinical trials Pharmacoepidemiol Drug Saf 19:1287–1292

    Google Scholar 

Download references

Acknowledgments

This study was supported by NIH grants U01 DK58231, U01 DK60379, U01 DK60380, U01 DK60401, U01 DK60397, U01 DK 58225, U01 DK60395, U01 DK58234, U01 DK60393, U01 DK58229.

Conflicts of interest

The authors report no financial disclosures with the following exceptions: Linda Brubaker received grant support and honorarium from Pfizer; Toby Chai received grant support from Allergan and honorarium from Pfizer; Anne Stoddard has stocks in Bristol-Meyers Squibb, Johnson and Johnson, Elan Corp., Proctor and Gamble, and Stryker.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ingrid Nygaard.

Appendix

Appendix

For SISTEr

Steering committee

William Steers, M.D., Chair (University of Virginia Charlottesville, VA); Ananias Diokno, M.D., Veronica Mallett, M.D. (William Beaumont Hospital, Royal Oak, MI, and Oakwood Hospital, Dearborn, MI; U01 DK58231); Linda Brubaker, M.D., and MaryPat FitzGerald, M.D. (Loyola University Medical Center, Maywood, IL; U01 DK60379); Holly E. Richter, Ph.D., M.D., L. Keith Lloyd, M.D. (University of Alabama, Birmingham, AL; U01 DK60380); Michael Albo, M.D., Charles Nager, M.D. (University of California, San Diego, CA; U01 DK60401); Toby C. Chai, M.D.; Harry W. Johnson, M.D. (University of Maryland, Baltimore, M.D.; U01 DK60397); Halina M. Zyczynski, M.D.; Wendy Leng, M.D. (University of Pittsburgh, Pittsburgh, PA; U01 DK 58225); Philippe Zimmern, M.D.; Gary Lemack, M.D. (University of Texas Southwestern, Dallas, TX; U01 DK60395); Stephen Kraus, M.D.; Thomas Rozanski, M.D. (University of Texas Health Sciences Center, San Antonio, TX; U01 DK58234); Peggy Norton, M.D.; David Lesser, M.D. (University of Utah, Salt Lake City, UT; U01 DK60393); Sharon Tennstedt, Ph.D.; Anne Stoddard, ScD (New England Research Institutes, Watertown, MA; U01 DK58229); Debuene Chang, M.D.; John W. Kusek, Ph.D.; Leroy M. Nyberg, M.D., Ph.D. (National Institute of Diabetes & Digestive & Kidney Diseases); Anne M. Weber, M.D. (National Institute of Child Health and Human Development).

Co-investigators

Rowell S. Ashford II, M.D.; Jan Baker, APRN; Diane Borello-France, PT, Ph.D.; Kathryn L. Burgio, Ph.D.; Seine Chiang, M.D.; Ash Dabbous, M.D.; Patricia S. Goode, M.D.; Lee N. Hammontree, M.D.; Kimberly Kenton, M.D.; Salil Khandwala, M.D.; Karl Luber, M.D.; Emily Lukacz, M.D.; Shawn Menefee, M.D.; Pamela Moalli, M.D.; Kenneth Peters, M.D.; Elizabeth Sagan, M.D.; Joseph Schaffer, M.D.; Amanda Simsiman, M.D.; Larry Sirls, M.D.; Robert Starr, M.D.; R. Edward Varner, M.D..

Study coordinators

Rosemary Bradt, RNC; Karen Debes, RN; Rosanna Dinh, RN, CCRC; Judy Gruss, RN; Lynn Hall, RN, MSN, CURN; Alice Howell, RN, BSN, CCRC; Kathy Jesse, RN; D. Lynn Kalinoski, Ph.D.; Kathryn Koches, RN; Barbara Leemon, RN; Karen Mislanovich, RN; Shelly O'Meara, RN; Janese Parent, RN; Norma Pope, RN; Caren Prather, RN; Terry Rogers, RN; Sylvia Sluder, CCRP; Mary Tulke, RN.

Biostatistical coordinating center

Kimberly J. Dandreo, MSc; Corinne J. Leifer, BA; Susan M. McDermott, MPH, GNP; Anne Stoddard, ScD (Co-PI); Sharon Tennstedt, Ph.D. (PI); Liane Tinsley, MPH; Lisa Wruck, ScD; Yan Xu, MS.

Data safety and monitoring board

Elizabeth A. Gormley, M.D. (Chair), Dartmouth-Hitchcock Medical Center, Lebanon NH; Paul Abrams, M.D., Bristol Urological Institute, Bristol, UK; Diedre Bland, M.D., Blue Ridge Medical Associates, Winston Salem NC; J. Quentin Clemens, M.D., Northwestern University Medical School, Chicago, IL; John Connett, Ph.D., University of Minnesota, Minneapolis, MN; William Henderson, Ph.D., University of Colorado, Aurora, CO; Dee Fenner, M.D., University of Michigan; Ann Arbor, MI; Sheryl Kelsey, Ph.D., University of Pittsburgh, Pittsburgh, PA; Deborah Myers, M.D., Brown University School of Medicine, Providence, RI; Jacek Mostwin, M.D., Johns Hopkins Hospital, Baltimore, MD; Bassem Wadie, MBBCh, MSc, M.D., Mansoura Urology and Nephrology Center, Mansoura, Egypt.

For TOMUS

Steering committee

Elizabeth A. Gormley, Chair (Dartmouth-Hitchcock Medical Center, Lebanon, NH); Larry Sirls, M.D.; Salil Khandwala, M.D. (William Beaumont Hospital, Royal Oak, MI, and Oakwood Hospital, Dearborn, MI; U01 DK58231); Linda Brubaker, M.D.; Kimberly Kenton, M.D. (Loyola University Chicago, Stritch School of Medicine, Maywood, IL; U01 DK60379); Holly E. Richter, Ph.D., M.D.; L. Keith Lloyd, M.D. (University of Alabama, Birmingham, AL; U01 DK60380); Michael Albo, M.D.; Charles Nager, M.D. (University of California, San Diego, CA; U01 DK60401); Toby C. Chai, M.D.; Harry W. Johnson, M.D. (University of Maryland, Baltimore, MD; U01 DK60397); Halina M. Zyczynski, M.D.; Wendy Leng, M.D. (University of Pittsburgh, Pittsburgh, PA; U01 DK 58225); Philippe Zimmern, M.D.; Gary Lemack, M.D. (University of Texas Southwestern, Dallas, TX; U01 DK60395); Stephen Kraus, M.D.; Thomas Rozanski, M.D. (University of Texas Health Sciences Center, San Antonio, TX; U01 DK58234); Peggy Norton, M.D.; Ingrid Nygaard, M.D. (University of Utah, Salt Lake City, UT; U01 DK60393); Sharon Tennstedt, Ph.D.; Anne Stoddard, ScD (New England Research Institutes, Watertown, MA; U01 DK58229); Debuene Chang, M.D. (until 10/2009), John Kusek, Ph.D. (starting 10/2009), Rebekah Rasooly, Ph.D. (National Institute of Diabetes & Digestive & Kidney Diseases).

Co-investigators

Amy Arisco, M.D.; Jan Baker, APRN; Diane Borello-France, PT, Ph.D.; Kathryn L. Burgio, Ph.D.; Ananias Diokno, M.D.; MaryPat Fitzgerald, M.D.; Chiara Ghetti, M.D.; Patricia S. Goode, M.D.; Robert L. Holley, M.D.; Yvonne Hsu, M.D.; Margie Kahn, M.D.; Jerry Lowder, M.D.; Karl Luber, M.D.; Emily Lukacz, M.D.; Alayne Markland, DO, MSc; Shawn Menefee, M.D.; Pamela Moalli, M.D.; Elizabeth Mueller, M.D.; Leslie Rickey, M.D., MPH; Elizabeth Sagan, M.D.; Joseph Schaffer, M.D.; Robert Starr, M.D.; Gary Sutkin, M.D.; R. Edward Varner, M.D.; Emily Whitcomb, M.D..

Study coordinators

Laura Burr, RN; JoAnn Columbo, BS, CCRC; Tamara Dickinson, RN, CURN, CCCN, BCIA-PMDB; Rosanna Dinh, RN, CCRC; Judy Gruss, RN; Alice Howell, RN, BSN, CCRC; Chaandini Jayachandran, MSc; Kathy Jesse, RN; D. Lynn Kalinoski, Ph.D.; Barbara Leemon, RN; Karen Mislanovich, RN; Elva Kelly Moore, RN; Caren Prather, RN; Jennifer Tabaldo; Tia Thrasher; Mary Tulke, RN; Robin Willingham, RN, BSN; Kimberly Woodson, RN, MPH; Gisselle Zazueta-Damian.

Data coordinating center

Kathleen Cannon, BS; Kimberly J. Dandreo, MSc; Liyuan Huang, MS; Rose Kowalski, MA; Heather Litman, Ph.D.; Marina Mihova, MHA; Anne Stoddard, ScD (Co-PI); Kerry Tanwar, BA; Sharon Tennstedt, Ph.D. (PI); Yan Xu, MS.

Data safety and monitoring board

J. Quentin Clemens, M.D. (Chair) Northwestern University Medical School, Chicago IL; Paul Abrams, M.D., Bristol Urological Institute, Bristol, UK; Deidre Bland, M.D., Blue Ridge Medical Associates, Winston Salem, NC; Timothy B. Boone, M.D., The Methodist Hospital, Baylor College of Medicine, Houston, TX; John Connett, Ph.D., University of Minnesota, Minneapolis, MN; Dee Fenner M.D., University of Michigan, Ann Arbor, MI; William Henderson, Ph.D., University of Colorado, Aurora, CO; Sheryl Kelsey, Ph.D., University of Pittsburgh, Pittsburgh, PA; Deborah J. Lightner, M.D., Mayo Clinic, Rochester, MN; Deborah Myers, M.D., Brown University School of Medicine, Providence, RI; Bassem Wadie, MBBCh, MSc, M.D., Mansoura Urology and Nephrology Center, Mansoura, Egypt; J. Christian Winters, M.D., Louisiana State University Health Sciences Center, New Orleans, LA

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nygaard, I., Brubaker, L., Chai, T.C. et al. Risk factors for urinary tract infection following incontinence surgery. Int Urogynecol J 22, 1255–1265 (2011). https://doi.org/10.1007/s00192-011-1429-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-011-1429-9

Keywords

Navigation